Maxim Group Upgrades Titan Pharmaceuticals (TTNP) to Buy

February 18, 2021 8:13 AM EST
Get Alerts TTNP Hot Sheet
Price: $2.72 -5.56%

Rating Summary:
    1 Buy, 1 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 17 | Down: 14 | New: 42
Trade Now! 
Join SI Premium – FREE

Maxim Group analyst Jason McCarthy upgraded Titan Pharmaceuticals (NASDAQ: TTNP) from Hold to Buy with a price target of $11.00.

For an analyst ratings summary and ratings history on Titan Pharmaceuticals click here. For more ratings news on Titan Pharmaceuticals click here.

Shares of Titan Pharmaceuticals closed at $4.18 yesterday.

You May Also Be Interested In

Related Categories

Hot Upgrades, Upgrades